Dr. Hosseini is a computational/cognitive neuroscientist investigating large-scale structural and functional brain networks in various neuropsychiatric disorders using multimodal neuroimaging, graph theoretical and multivariate pattern analyses techniques.

Dr. Dunn's research interests include intestinal lengthening for short bowel syndrome, intestinal stem cell therapy for intestinal failure, skin derived precursor cell therapy for enteric neuromuscular dysfunction, and intestinal tissue engineering.

A key focus of Dr. Hernandez-Boussard's research is the application of novel methods and tools to large clinical datasets for hypothesis generation, comparative effectiveness research, and the evaluation of quality healthcare delivery.

Dr. Jackson’s lab uses proteomics and advanced imaging techniques to study fundamental mechanisms of cell biology. He has made a broad set of discoveries related to regulatory complexes and signaling in the cell cycle, cancer, signaling within the primary cilium and the link between cilia and human genetic diseases.

Dr. Wernig's lab focuses on understanding the pathomechanisms of end stage organ fibrosis with the ultimate goal to help identify new targets for effective therapies.

Dr. Simons's research projects focus on biological, neurological, cognitive, affective, and social risk and resiliency factors of the pain experience.

Studies conducted in the Weinacht lab aim to understand how defects in mitochondrial metabolism and increased oxidative stress lead to impaired hematopoietic stem and progenitor cell development.

Dr. Ling's research interests center on hypothesis driven, big data empowered, translational discovery.

The Huberman lab is focused on brain function, development and repair with emphasis on regeneration to prevent and cure blindness.

The Soltesz lab is interested in how brain cells communicate with each other in the normal brain, and how the communication changes in epilepsy.